Learn more about lung cancer at [ Ссылка ]
Dr. Shanda Blackmon, director of cancer surgery from The Lung Institute at Baylor College of Medicine, explains what comprehensive biomarker testing for lung cancer is and what you need to know. She describes how comprehensive biomarker testing looks to identify specific genetic markers, or molecular markers, that may indicate the presence of a specific type of cancer that can be treated. If the genetic markers identified have known treatments available, these can be used to treat your lung cancer in situations where traditional treatments may not work. If you are interested in having comprehensive biomarker testing, Dr. Blackmon recommends you have a conversation with your medical oncologist about this topic since every institution is different, and frequently there are many clinical trials that patients can enroll into that cover the cost of molecular testing.
